Company / Revenue
Yubo International Biotech Ltd Revenue History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$12.4K
FY2025
5-year range
$0 / $604.7K
FY2021-FY2025
Trend
+256.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue changed +256% YoY in FY2025, a notable deviation from the 3-year average annual change of +212%.
Based on SEC 10-K filings.
$12,353 in FY2025 with a 3-year CAGR of -50.9%.
Declined from $604,676 to $12,353 over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- -50.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -50.9%, indicating a declining trend.
- In FY2025, revenue increased 256.0% year-over-year.
- Peak revenue was recorded in FY2023.
- Lowest revenue in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -14.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $12.4K | +256.0% |
| FY2024 | $3.5K | -99.4% |
| FY2023 | $604.7K | +479.8% |
| FY2022 | $104.3K | - |
| FY2020 | $0 | - |
| FY2019 | $0 | - |
| FY2018 | $0 | - |
| FY2017 | $0 | - |
| FY2016 | $0 | - |
| FY2015 | $0 | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026